NUSAP1 and PCLAF (KIA0101) Downregulation by Neoadjuvant Therapy is Associated with Better Therapeutic Outcomes and Survival in Breast Cancer

PURPOSE: To evaluate whether changes in genomic expression that occur beginning with breast cancer (BC) diagnosis and through to tumor resection after neoadjuvant chemotherapy (NCT) reveal biomarkers that can help predict therapeutic response and survival. MATERIALS AND METHODS: We determined gene e...

Descripción completa

Detalles Bibliográficos
Autores principales: Magallanes-Garza, Gerardo I., Santuario-Facio, Sandra K., Lira-Albarrán, Saúl, Varela-Varela, Arlina F., Cardona-Huerta, Servando, Ruiz-Flores, Pablo, Haro-Santa-Cruz, Jorge, Perez-Paramo, Yadira X., Gomez-Macias, Gabriela Sofia, Davila-Gonzalez, Daniel, Valero-Gomez, Javier, Borrego-Soto, Gissela, Rojas-Martinez, Augusto, Ortiz-Lopez, Rocio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722309/
https://www.ncbi.nlm.nih.gov/pubmed/36478748
http://dx.doi.org/10.1155/2022/6001947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722309/
https://www.ncbi.nlm.nih.gov/pubmed/36478748
http://dx.doi.org/10.1155/2022/6001947

Ejemplares similares